HomeCDXS • NASDAQ
add
Codexis Inc
Previous close
$2.65
Day range
$2.62 - $2.74
Year range
$1.45 - $4.91
Market cap
187.01M USD
Avg Volume
405.92K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 26.56M | -12.56% |
Operating expense | 12.18M | -1.05% |
Net income | -7.19M | 42.94% |
Net profit margin | -27.08 | 34.73% |
Earnings per share | -0.10 | 28.12% |
EBITDA | 1.50M | 117.36% |
Effective tax rate | -0.49% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 65.12M | -42.87% |
Total assets | 136.56M | -45.46% |
Total liabilities | 49.95M | -52.70% |
Total equity | 86.62M | — |
Shares outstanding | 70.30M | — |
Price to book | 2.14 | — |
Return on assets | 0.48% | — |
Return on capital | 0.66% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -7.19M | 42.94% |
Cash from operations | -11.04M | -324.47% |
Cash from investing | 1.10M | 3,245.45% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -9.93M | -287.80% |
Free cash flow | 5.18M | 8.77% |
About
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications. Wikipedia
CEO
Founded
2002
Headquarters
Website
Employees
174